Differential Expression of Homing Receptor Ligands on Tumor-Associated Vasculature that Control CD8 Effector T-cell Entry

Cancer Immunology Research
Amber N WoodsVictor H Engelhard

Abstract

Although CD8+ T cells are critical for controlling tumors, how they are recruited and home to primary and metastatic lesions is incompletely understood. We characterized the homing receptor (HR) ligands on tumor vasculature to determine what drives their expression and their role in T-cell entry. The anatomic location of B16-OVA tumors affected the expression of E-selectin, MadCAM-1, and VCAM-1, whereas the HR ligands CXCL9 and ICAM-1 were expressed on the vasculature regardless of location. VCAM-1 and CXCL9 expression was induced by IFNγ-secreting adaptive immune cells. VCAM-1 and CXCL9/10 enabled CD8+ T-cell effectors expressing α4β1 integrin and CXCR3 to enter both subcutaneous and peritoneal tumors, whereas E-selectin enabled E-selectin ligand+ effectors to enter subcutaneous tumors. However, MadCAM-1 did not mediate α4β7+ effector entry into peritoneal tumors due to an unexpected lack of luminal expression. These data establish the relative importance of certain HRs expressed on activated effectors and certain HR ligands expressed on tumor vasculature in the effective immune control of tumors. Cancer Immunol Res; 5(12); 1062-73. ©2017 AACR.

References

Mar 1, 1995·The Journal of Cell Biology·R AlonT A Springer
Nov 1, 1995·The Journal of Experimental Medicine·F LiaoJ M Farber
Mar 11, 2000·The Journal of Clinical Investigation·M H SiegelmanP Estess
Nov 21, 2000·The Journal of Experimental Medicine·W W HancockC Gerard
Oct 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·D W MullinsV H Engelhard
Jul 4, 2003·Nature·J Rodrigo MoraUlrich H Von Andrian
Mar 25, 2004·Nature Reviews. Immunology·Thomas S Kupper, Robert C Fuhlbrigge
May 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Natalio GarbiRuth Ganss
Jan 12, 2005·The Journal of Experimental Medicine·J Rodrigo MoraUlrich H von Andrian
Oct 24, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kristian M HargadonVictor H Engelhard
May 5, 2007·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Xisheng WangYasuhiro Suzuki
Jul 10, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lisa A NicholsVictor H Engelhard
Aug 25, 2007·Nature Reviews. Immunology·Klaus LeySussan Nourshargh
Aug 25, 2007·Cancer Metastasis Reviews·Femke Hillen, Arjan W Griffioen
Aug 20, 2008·Nature Immunology·Hekla Sigmundsdottir, Eugene C Butcher
Mar 10, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andrew R Ferguson, Victor H Engelhard
Mar 24, 2010·The Journal of Experimental Medicine·Jarish N CohenVictor H Engelhard
Dec 21, 2010·International Journal of Cancer. Journal International Du Cancer·Anamika BoseWalter J Storkus
Jan 12, 2011·Immunology and Cell Biology·Joanna R Groom, Andrew D Luster
Apr 12, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer LohrChristel Herold-Mende
Sep 20, 2011·The Journal of Clinical Investigation·Daniel T FisherSharon S Evans
Dec 8, 2011·Cancer Immunology, Immunotherapy : CII·Rui-Ru JiVafa Shahabi
Mar 9, 2012·The New England Journal of Medicine·Michael A PostowJedd D Wolchok
Mar 23, 2012·Nature Reviews. Immunology·Nicholas P RestifoSteven A Rosenberg
May 30, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fernando Ulloa-MontoyaVincent G Brichard
Jul 29, 2015·Advances in Cancer Research·J David PeskeVictor H Engelhard

❮ Previous
Next ❯

Citations

Jan 10, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Victor H EngelhardCraig L Slingluff
Nov 18, 2018·Expert Opinion on Therapeutic Patents·Hao LiJi-Fu Wei
Apr 20, 2018·Cancer Immunology, Immunotherapy : CII·Paulina AkeusMarianne Quiding-Järbrink
Aug 10, 2019·Frontiers in Immunology·Michael SchulzLisa Sevenich
May 7, 2020·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Sabrina CavinJean Y Perentes
Mar 27, 2020·Frontiers in Oncology·Avishek BhuniyaRathindranath Baral
Apr 11, 2020·Nature Communications·Andrew J GundersonKristina H Young
Nov 11, 2018·British Journal of Cancer·Nicolas A GiraldoCatherine Sautès-Fridman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Related Papers

The Journal of Immunology : Official Journal of the American Association of Immunologists
Andrew R Ferguson, Victor H Engelhard
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
Xisheng WangYasuhiro Suzuki
Immunology and Cell Biology
Joanna R Groom, Andrew D Luster
© 2022 Meta ULC. All rights reserved